Tocarciuc Ala

About

Ala Tocarciuc is a renowned executive in the pharmaceutical industry, with a career spanning over three decades marked by remarkable achievements in leading companies and transforming emerging markets. Originally from the Republic of Moldova, she has built a solid reputation as a specialist in crisis management, organizational restructuring, and strategic development in Eastern European and Central Asian markets. Her academic background includes a degree in Pharmacy from the Chisinau Institute of Medicine and a Master's in Business Administration from Grenoble École de Management, which have strengthened both her technical knowledge and managerial skills. Throughout her career, Ala Tocarciuc has held senior executive positions at prestigious international pharmaceutical companies, where she has significantly contributed to regional expansion and revenue growth. In her role as General Manager at Roche Moldova and subsequently Head of Sub-Region Ukraine, she demonstrated exceptional leadership capabilities, successfully doubling annual sales and transforming operations into profit centers. Her experience also includes managerial roles at Shire Pharmaceuticals and PTC Therapeutics, where she coordinated the launch of innovative products for rare diseases and oversaw complex market access processes in the CIS region. As Chief Executive Officer at Almeda Pharmaceuticals AG, a company registered in Zug, Switzerland, since 2021, Ala Tocarciuc has full responsibility for the commercial strategy, financial planning, and operations of the entire organization. She is an author and columnist, with publications dedicated to crisis management and modern pharmacy practices, and has contributed to academic research on the attitudes of pharmacists in Moldova. In addition to her current executive role, she maintains a global perspective on digital transformation and innovation in the pharmaceutical sector, being involved in research initiatives in the field of synthetic organs and advanced technologies.